Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 10 | 2023 | 10900 | 0.960 |
Why?
|
Masks | 1 | 2020 | 197 | 0.630 |
Why?
|
Ventricular Function, Left | 6 | 2023 | 3670 | 0.620 |
Why?
|
Eligibility Determination | 1 | 2020 | 403 | 0.560 |
Why?
|
Heart-Assist Devices | 3 | 2021 | 1194 | 0.550 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3158 | 0.520 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 642 | 0.510 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.500 |
Why?
|
Cardiology | 2 | 2021 | 1668 | 0.450 |
Why?
|
Selenium | 1 | 2016 | 405 | 0.450 |
Why?
|
Infection Control | 1 | 2020 | 966 | 0.440 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2020 | 1344 | 0.390 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1912 | 0.370 |
Why?
|
Stroke Volume | 8 | 2023 | 5007 | 0.370 |
Why?
|
Myocytes, Cardiac | 2 | 2016 | 1637 | 0.360 |
Why?
|
Medicaid | 2 | 2020 | 2736 | 0.350 |
Why?
|
Health Personnel | 1 | 2020 | 3218 | 0.290 |
Why?
|
Fibroblasts | 1 | 2016 | 4161 | 0.260 |
Why?
|
Prosthesis-Related Infections | 2 | 2021 | 538 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.250 |
Why?
|
Heart Transplantation | 1 | 2018 | 3110 | 0.250 |
Why?
|
Sex Characteristics | 3 | 2023 | 2585 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.240 |
Why?
|
Pandemics | 3 | 2021 | 8388 | 0.240 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11727 | 0.230 |
Why?
|
Ramipril | 1 | 2023 | 95 | 0.220 |
Why?
|
MicroRNAs | 1 | 2016 | 3752 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15165 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Sodium | 1 | 2022 | 1623 | 0.150 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 845 | 0.140 |
Why?
|
Eicosapentaenoic Acid | 1 | 2020 | 582 | 0.140 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2016 | 223 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
SOXB1 Transcription Factors | 1 | 2016 | 284 | 0.120 |
Why?
|
Culture Media | 1 | 2016 | 908 | 0.120 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.110 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2016 | 504 | 0.110 |
Why?
|
Recovery of Function | 2 | 2020 | 2925 | 0.100 |
Why?
|
Humans | 17 | 2023 | 744343 | 0.100 |
Why?
|
Income | 1 | 2020 | 1913 | 0.100 |
Why?
|
Glucose | 1 | 2022 | 4397 | 0.090 |
Why?
|
Animals, Newborn | 1 | 2016 | 2726 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2020 | 2050 | 0.090 |
Why?
|
RNA Interference | 2 | 2016 | 2889 | 0.090 |
Why?
|
Insurance Coverage | 1 | 2020 | 1901 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2376 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1663 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2016 | 11483 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.080 |
Why?
|
Male | 8 | 2023 | 350118 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.070 |
Why?
|
Hospitalization | 2 | 2023 | 10262 | 0.070 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.060 |
Why?
|
Female | 6 | 2023 | 380194 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18370 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7799 | 0.050 |
Why?
|
United States | 2 | 2020 | 69872 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6580 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.050 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2020 | 67 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2023 | 63114 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6566 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2023 | 57776 | 0.040 |
Why?
|
Chloroquine | 1 | 2020 | 280 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2014 | 10481 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.040 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 125 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 275 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.040 |
Why?
|
Alanine | 1 | 2020 | 572 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 412 | 0.030 |
Why?
|
Virus Internalization | 1 | 2020 | 501 | 0.030 |
Why?
|
Adult | 2 | 2020 | 214055 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
Emergencies | 1 | 2021 | 1170 | 0.030 |
Why?
|
Young Adult | 1 | 2020 | 56430 | 0.030 |
Why?
|
Aorta | 1 | 2021 | 2061 | 0.030 |
Why?
|
Antimalarials | 1 | 2020 | 905 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7181 | 0.030 |
Why?
|
Middle Aged | 3 | 2023 | 213383 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 85781 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2531 | 0.020 |
Why?
|
Aged | 2 | 2023 | 163280 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1726 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1227 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8340 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1585 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2987 | 0.020 |
Why?
|
Animals | 2 | 2016 | 168757 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5892 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.020 |
Why?
|
Regeneration | 1 | 2014 | 1485 | 0.020 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14557 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19229 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18029 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23403 | 0.010 |
Why?
|
Concepts
(108)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_